OMAHA, Neb. (WOWT) - The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or Zepbound were previously in a shortage.

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...

A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...

Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.

Since Ozempic hit the ... against our biology”. The FDA, his prior workplace, sets guidelines around food safety, he points out. But, he asks, why there are no regulations protecting the ...

News last week that a CNN investigative report found dozens of fake podcasts on the popular audio streaming and media service platform Spotify, illegally ...

Online prescriptions – for everything from weight loss to medicinal cannabis – is now a big business backed by Woolworths and ...